The DOI matches its Crossref record; 100 of the 100 references it cites were found in a registry or an index.
Microneedles for intradermal and transdermal drug delivery
Open accessAbstract
The formidable barrier properties of the uppermost layer of the skin, the stratum corneum impose significant limitations for successful systemic delivery of a broad range of therapeutic molecules, particularly macromolecules and genetic material. Microneedle delivery has been proposed as a strategy to breach the SC barrier function in order to facilitate effective transport of molecules across the skin. This strategy involves the use of micron sized needles fabricated from different materials and using different geometries to create transient aqueous conduits across the skin. Microneedles in isolation, or in combination with other enhancing strategies, have been shown to dramatically enhance the skin permeability of numerous therapeutic molecules including biopharmaceuticals either in vitro, ex vivo or in vivo. Progress in the areas of microneedle design, development and manufacture have proven promising in terms of the potential use of this emerging delivery method in clinical applications such as insulin delivery, transcutaneous immunisations and cutaneous gene delivery. This review article focuses on recent and potential future developments in microneedle technologies. This will include the detailing of progress made in microneedle design, an exploration of the challenges faced in this field and potential forward strategies to embrace the exploitation of microneedle methodologies, while considering the inherent safety aspects of such therapeutic tools.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prausnitz, M. R., & Langer, R. (2008) · Nature Biotechnology · doi:10.1038/nbt.1504 · Cited by 3,517
Microneedles for drug and vaccine delivery
Kim, Y.-C., Park, J.-H., & Prausnitz, M. R. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.04.005 · Cited by 1,760
Microneedles for transdermal drug delivery
Prausnitz, M. R. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.10.023 · Cited by 1,521
Microfabricated Microneedles: A Novel Approach to Transdermal Drug Delivery
Henry, S., McAllister, D. V., Allen, M. G., & Prausnitz, M. R. (1998) · Journal of Pharmaceutical Sciences · doi:10.1021/js980042+ · Cited by 1,346
Biodegradable polymer microneedles: Fabrication, mechanics and transdermal drug delivery
Park, J.-H., Allen, M. G., & Prausnitz, M. R. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.02.002 · Cited by 1,026
Dissolving microneedles for transdermal drug delivery
Lee, J. W., Park, J.-H., & Prausnitz, M. R. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2007.12.048 · Cited by 968
Dissolving polymer microneedle patches for influenza vaccination
Sullivan, S. P., Koutsonanos, D. G., del Pilar Martin, M., Lee, J. W., Zarnitsyn, V., Choi, S.-O., Murthy, N., Compans, R. W., Skountzou, I., & Prausnitz, M. R. (2010) · Nature Medicine · doi:10.1038/nm.2182 · Cited by 948
Davis, S. P., Landis, B. J., Adams, Z. H., Allen, M. G., & Prausnitz, M. R. (2004) · Journal of Biomechanics · doi:10.1016/j.jbiomech.2003.12.010 · Cited by 934
McAllister, D. V., Wang, P. M., Davis, S. P., Park, J.-H., Canatella, P. J., Allen, M. G., & Prausnitz, M. R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2331316100 · Cited by 859 · cited 13×
“An approximate twofold increment in the permeation of the model peptide (bovine insulin), in addition to a nearly threefold increase in model protein permeation (fluorescein isothiocyanate – labelled bovine serum albumin, FTIC-BSA) were observed across neonatal porcine skin after a 6 h period.”
MethodInfluentialCoated microneedles for transdermal delivery
Gill, H. S., & Prausnitz, M. R. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.10.017 · Cited by 765
Cited by
Alkilani, A., McCrudden, M. T., & Donnelly, R. (2015) · Pharmaceutics · doi:10.3390/pharmaceutics7040438 · Cited by 1,147
Self-citationLarrañeta, E., Lutton, R. E. M., Woolfson, A. D., & Donnelly, R. F. (2016) · Materials Science and Engineering: R: Reports · doi:10.1016/j.mser.2016.03.001 · Cited by 964
Self-citationCurrent trends in polymer microneedle for transdermal drug delivery
Ahmed Saeed AL-Japairai, K., Mahmood, S., Hamed Almurisi, S., Reddy Venugopal, J., Rebhi Hilles, A., Azmana, M., & Raman, S. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2020.119673 · Cited by 448
Hydrogel‐Forming Microneedles: Current Advancements and Future Trends
Turner, J. G., White, L. R., Estrela, P., & Leese, H. S. (2021) · Macromolecular Bioscience · doi:10.1002/mabi.202000307 · Cited by 413
Device-assisted transdermal drug delivery
Lee, H., Song, C., Baik, S., Kim, D., Hyeon, T., & Kim, D.-H. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.08.009 · Cited by 343
Microneedles: A New Frontier in Nanomedicine Delivery
Larrañeta, E., McCrudden, M. T. C., Courtenay, A. J., & Donnelly, R. F. (2016) · Pharmaceutical Research · doi:10.1007/s11095-016-1885-5 · Cited by 339
Self-citationRecent advances in the design of polymeric microneedles for transdermal drug delivery and biosensing
Wang, M., Hu, L., & Xu, C. (2017) · Lab on a Chip · doi:10.1039/c7lc00016b · Cited by 285
Ling, M.-H., & Chen, M.-C. (2013) · Acta Biomaterialia · doi:10.1016/j.actbio.2013.06.029 · Cited by 280
Hydrogel-forming microneedles enhance transdermal delivery of metformin hydrochloride
Migdadi, E. M., Courtenay, A. J., Tekko, I. A., McCrudden, M. T. C., Kearney, M.-C., McAlister, E., McCarthy, H. O., & Donnelly, R. F. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.07.009 · Cited by 279
Self-citationTransdermal drug delivery: 30 + years of war and still fighting!
Wiedersberg, S., & Guy, R. H. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.05.022 · Cited by 278
Insulin delivery systems combined with microneedle technology
Jin, X., Zhu, D. D., Chen, B. Z., Ashfaq, M., & Guo, X. D. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.03.011 · Cited by 275
Microneedle array systems for long-acting drug delivery
Vora, L. K., Moffatt, K., Tekko, I. A., Paredes, A. J., Volpe-Zanutto, F., Mishra, D., Peng, K., Raj Singh Thakur, R., & Donnelly, R. F. (2021) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2020.12.006 · Cited by 270
Self-citationMicroneedles as the technique of drug delivery enhancement in diverse organs and tissues
Rzhevskiy, A. S., Singh, T. R. R., Donnelly, R. F., & Anissimov, Y. G. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.11.048 · Cited by 266
Self-citationMicroneedle-mediated transdermal drug delivery for treating diverse skin diseases
Yang, D., Chen, M., Sun, Y., Jin, Y., Lu, C., Pan, X., Quan, G., & Wu, C. (2021) · Acta Biomaterialia · doi:10.1016/j.actbio.2020.12.004 · Cited by 259
High frequency ultrasound to assess skin thickness in healthy adults
Van Mulder, T. J. S., de Koeijer, M., Theeten, H., Willems, D., Van Damme, P., Demolder, M., De Meyer, G., Beyers, K. C. L., & Vankerckhoven, V. (2017) · Vaccine · doi:10.1016/j.vaccine.2016.07.039 · Cited by 89
Vaccination into the Dermal Compartment: Techniques, Challenges, and Prospects
Hettinga, J., & Carlisle, R. (2020) · Vaccines · doi:10.3390/vaccines8030534 · Cited by 72
Metadata
- Authors
- Tuan-Mahmood, T.-M., McCrudden, M. T. C., Torrisi, B. M., McAlister, E., Garland, M. J., Singh, T. R. R., & Donnelly, R. F.
- Venue
- European Journal of Pharmaceutical Sciences
- Publisher
- Elsevier BV
- Published
- 2013-12
- Volume
- 50
- Issue
- 5
- Pages
- 623-637
- ISSN
- 0928-0987 (ISSN-L)
- OpenAlex
- W2012594431
- Cited by
- 468
- References
- 100
- FWCI
- 15.39
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.